Phase 1 Irritable Bowel Syndrome Trial, Recruiting NCT06960369 Sponsor: The First Affiliated Hospital of Soochow University Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Phase 1 Irritable Bowel Syndrome Trial, Recruiting

NCT06960369
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Irritable Bowel Syndrome (IBS) according to specific standard diagnostic guidelines called the Rome IV criteria.
  • You are between 18 and 70 years old.
  • You have had IBS symptoms for more than 6 months.
  • Tests have not found any physical or chemical abnormalities that explain your bowel symptoms.
  • Your IBS symptoms are at least at a certain level of severity as measured by a standard scoring tool (a score of 75 or above at the start of the trial).
  • You have not taken any regular medication for IBS (other than emergency treatment) for at least 2 weeks before the trial starts, and you are not currently taking part in another clinical trial.
  • You are willing to voluntarily sign a consent form and participate in the trial.

Who may not be able to join:

  • You are under 18 or over 70 years old.
  • You have serious liver, kidney, blood, heart, brain, or mental health conditions that significantly affect how you think or function.
  • You have a known physical disease of the intestines, conditions like diabetes or an overactive thyroid that affect digestion, or you have previously had surgery on your bowel, anus, or abdomen.
  • You regularly take medications or treatments that affect how your digestive system moves or works, or you are using other treatments that might affect the trial results.
  • You are pregnant, breastfeeding, or have given birth within the last 12 months.
  • You have a severe fear of needles, an allergy or sensitivity to metal, or you have a pacemaker.
  • You are unlikely to follow the trial's treatment plan as assigned, or your ability to stick to the trial requirements is considered unreliable.
  • You are currently taking part in another research study.
  • You are not willing to sign the consent form.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Rui Li, Rui Li Study Principal Investigator The First Affiliated Hospital of Soochow University

Phone: +86 153 3952 5666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
The First Affiliated Hospital of Soochow University
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Frequency of defecation and Bristol Stool Form Scale score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov